Top 10 Clinical Guidance Updates for Physicians
-
By
-
mdspire news news staff
-
May 19, 2026
-
4 min
By
mdspire news news staff
May 19, 2026
Novartis reported less annual eGFR decline with iptacopan than placebo over 2 years in the phase 3 APPLAUSE-IgAN trial.
July 17, 2026
A national claims analysis found modest uptake and declining persistence over 2 years despite increasing use of injectable HIV pre-exposure prophylaxis.
July 17, 2026
A target trial emulation using Veterans Affairs electronic health records examined neuropsychiatric outcomes associated with SGLT2 inhibitor use.
July 31, 2026